J&J shots from Gqeberha facility delayed after mistake in key vaccine ingredient by US firm

PREMIUM

The release of SA’s first commercial shipment of Johnson & Johnson’s (J&J’s) Covid-19 vaccine from Aspen Pharmacare’s Gqeberha facility is being delayed as a “precautionary” safety measure after problems at a US company contracted by J&J to make a key vaccine ingredient, health minister Zweli Mkhize announced on Sunday...

This article is reserved for DispatchLIVE subscribers.

Get access to ALL DispatchLIVE content from only R45.00 per month.

Already subscribed? Simply sign in below.

Already registered on HeraldLIVE, BusinessLIVE, TimesLIVE or SowetanLIVE? Sign in with the same details.



Questions or problems? Email helpdesk@dispatchlive.co.za or call 0860 52 52 00.

Would you like to comment on this article or view other readers' comments? Register (it’s quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

X